GlaxoSmithKline Plc said on Wednesday the U.S health regulator approved its lung disease drug Trelegy Ellipta for expanded use, making it the first inhaler delivering three drugs at once to be ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback